Details of Disease

Disease Name

Excessive daytime sleepiness

Disease Class

MG42: Somnolence

Disease Hierarchy

DIS01GPL: Grass pollen hypersensitivity

DISI0RB1: Excessive daytime sleepiness

ICD-11

ICD-11: MG42

ICD-10

ICD-10: F51.1, G47.1

Expand ICD-9

291.82,292.85,307,327.1,780

Disease Identifiers

MONDO ID

MONDO_0005466

MESH ID

D006970

UMLS CUI

C0917799

MedGen ID

214588

HPO ID

HP:0100786

SNOMED CT ID

77692006

General Information of Disease (ID: DISI0RB1)

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)

This Disease is Treated as An Indication in 2 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Pitolisant	DM8RFNJ	Approved	Small molecular drug	[1]
Solriamfetol	DMCG4JG	Approved	NA	[2]
------------------------------------------------------------------------------------

This Disease is Treated as An Indication in 2 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
ADX N05	DMLBYRA	Phase 3	NA	[3]
MK-7288	DMJ2Q6H	Phase 1	NA	[4]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2019
2	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2019
3	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800030225)
4	ClinicalTrials.gov (NCT01092780) Pharmacodynamics and Efficacy of MK7288 (MK-7288-010). U.S. National Institutes of Health.